Core Points - The document outlines the management system for the resignation of directors and senior management personnel at Tianshui Zhongxing Mushroom Industry Technology Co., Ltd, aiming to ensure stable governance and protect the rights of the company and its shareholders [1][2]. Group 1: General Provisions - The system applies to all directors and senior management personnel, including independent directors and employee representatives, regarding their resignation, term expiration, or dismissal [1]. - The resignation procedures are established in accordance with relevant laws, regulations, and the company's articles of association [1]. Group 2: Resignation Circumstances and Procedures - Directors may resign due to term expiration, voluntary resignation, dismissal by the shareholders' meeting, or other legal circumstances [5]. - Senior management can resign voluntarily or be dismissed by the board of directors [6]. - A written resignation report must be submitted by directors, detailing the resignation time, reasons, and any continued roles within the company [7]. Group 3: Responsibilities and Obligations After Resignation - Directors and senior management must not use their former positions to interfere with the company's operations or harm the interests of the company and its shareholders after leaving [8]. - They are required to continue fulfilling any public commitments made during their tenure and cooperate with the company regarding any significant matters that occurred during their service [9]. Group 4: Audit and Accountability - The audit committee may initiate a departure audit for directors or senior management involved in significant investments or financial decisions [10]. - The results of the audit can serve as a basis for accountability and recovery of losses incurred by the company [10][11].

Core Points - The document outlines the operational guidelines for the General Manager of Tianshui Zhongxing Mushroom Industry Technology Co., Ltd, emphasizing the importance of legal compliance and the responsibilities of senior management [1][2][3] General Principles - The guidelines aim to enhance the corporate governance structure and ensure that the management team fulfills their duties diligently and in good faith [1] - Senior management includes the General Manager, Deputy General Managers, Financial Director, and Board Secretary [1] Appointment and Qualifications - The General Manager is appointed or dismissed by the Board of Directors and is responsible for daily operations and management [1][2] - Specific qualifications are required for the General Manager and senior management, including economic and management knowledge, integrity, and relevant experience [3][4] Powers and Responsibilities - The General Manager has the authority to manage daily operations, implement board resolutions, and propose appointments or dismissals of other senior management [12][13] - The General Manager must report to the Board of Directors and is responsible for significant operational decisions [12][16] Meeting Procedures - The company implements a General Manager's office meeting system to facilitate decision-making and management [21][22] - Meetings must adhere to principles of accountability to the Board, legal compliance, and efficiency [22][23] Reporting and Evaluation - The General Manager is required to report to the Board at least annually and must inform the Board of significant operational issues promptly [56][57] - Performance evaluations for the General Manager and senior management are conducted by the Board's Compensation and Assessment Committee [60][61]

Core Viewpoint - The board of directors of Shenzhen Biyimi Electronics Co., Ltd. held its 17th meeting of the second session, approving several key proposals including the 2025 semi-annual report, the cancellation of the supervisory board, and the implementation of a stock incentive plan [1][2][3][4][5][6][7][8][9][10][11][12]. Group 1: Board Meeting Details - The meeting was held on August 15, 2025, with all 7 directors present, complying with relevant laws and regulations [1]. - The board approved the 2025 semi-annual report, confirming its compliance with legal requirements and accurately reflecting the company's financial status [2]. Group 2: Financial Reports and Fund Usage - The board approved the special report on the storage and actual use of raised funds for the first half of 2025, confirming no violations in fund usage [2][3]. - The board agreed on the necessity of using raised funds for capital contributions and loans to wholly-owned subsidiaries to enhance project implementation and efficiency [6][7]. Group 3: Structural Changes - The board approved the cancellation of the supervisory board, transferring its responsibilities to the audit committee, and proposed amendments to the company’s articles of association [3][4]. - The board also agreed to revise and add certain management systems in accordance with updated regulations [4][5]. Group 4: Incentive Plans - The board reviewed and approved the draft of the 2025 restricted stock incentive plan, aimed at attracting and retaining talent while aligning interests among shareholders, the company, and employees [7][8]. - The board proposed to authorize the board to manage the implementation of the incentive plan, including determining eligibility and conditions for participants [9][10]. Group 5: Upcoming Shareholder Meeting - The board agreed to convene the first extraordinary general meeting of shareholders in 2025 on September 5, 2025, to discuss the approved proposals [11][12].

证券代码：688045 证券简称：必易微 公告编号：2025-031 深圳市必易微电子股份有限公司 关于取消监事会、修订《公司章程》并办理 工商变更登记及修订、新增部分管理制度的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 深圳市必易微电子股份有限公司（以下简称"公司"）于 2025 年 8 月 15 日召开了第二届董事会第十七次会议，审议通过了《关于取消监事会并修订 <公> 司章程>及办理工商变更登记的议案》《关于修订、新增公司部分管理制度的议 案》，现将相关情况公告如下： 一、取消监事会的情况 根据《中华人民共和国公司法》（以下简称"《公司法》"）、《上市公司 章程指引》的有关规定，上市公司将不再设置监事会及监事，由董事会审计委员 会行使《公司法》规定的监事会的职权。因此，公司拟取消监事会，由公司董事 会审计委员会行使《公司法》规定的监事会的职权，公司《监事会议事规则》相 应废止，公司各项规章制度中与公司监事、监事会相关的规定不再适用。 在公司股东大会审议通过取消监事会的事项前，公司第二届监事会及监事仍 将继续 ...

Group 1 - The company has decided to cancel its supervisory board to enhance governance efficiency and standardize operations, with the supervisory board's powers being transferred to the audit committee of the board of directors [1][2] - The company held its 13th board meeting on August 14, 2025, where three proposals regarding the revision of the company's articles of association and related rules were approved [1] - The revisions to the articles of association and related rules are aimed at improving the governance structure in accordance with relevant laws and regulations, and will be submitted for approval at the upcoming extraordinary general meeting of shareholders [2] Group 2 - The specific amendments to the articles of association, shareholder meeting rules, and board meeting rules will be published on the company's official information disclosure platform [2] - The board of directors will seek authorization from the shareholders' meeting to allow management to handle the necessary business registration and filing related to the amendments [2] - The company will disclose the full text of the revised articles of association and related rules after approval from the shareholders' meeting [2]

Core Points - The company is Shenzhen Kiwi Instruments Co., Ltd, established as a joint-stock company in accordance with Chinese laws and regulations [3][4] - The company was approved for registration by the China Securities Regulatory Commission and listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board in May 2022, with a registered capital of RMB 69.837819 million [3][4] - The company's business scope includes the development, consulting, and sales of electronic products, instruments, software, and integrated circuits [3][4] Chapter Summaries General Provisions - The company aims to protect the rights of shareholders and creditors while regulating its organization and operations [3] - The company is a permanent joint-stock entity with a legal representative who is also the chairman [3][4] Business Objectives and Scope - The company's mission emphasizes unique innovation, ease of use, sincerity, diligence, and win-win cooperation [3] - The operational scope includes technology development and sales related to electronic products and integrated circuits [3][4] Shares - The company issues shares in the form of stocks, with a total of 69.837819 million shares, all of which are ordinary shares [3][4] - The company can increase capital through various methods, including issuing shares to unspecified or specific targets [3][4] Shareholder Rights and Meetings - Shareholders have rights to dividends, participate in meetings, supervise operations, and transfer shares [3][4] - The company must hold annual and temporary shareholder meetings, with specific procedures for notifications and voting [3][4] Control and Responsibilities - The controlling shareholders and actual controllers must exercise their rights in compliance with laws and regulations, ensuring the company's interests are maintained [3][4] - Shareholders holding more than 5% of shares must disclose any pledges of their shares within two trading days [3][4]

General Overview - The document outlines the working rules of the Strategic Committee of Delong Composite Energy Group Co., Ltd, established to enhance investment decision-making and improve governance structure [1][2]. Composition of the Committee - The Strategic Committee consists of three directors, with a majority being independent directors [3]. - The chairman of the committee is the company's chairman, who also serves as the convener [2]. Responsibilities and Authority - The main responsibilities of the Strategic Committee include researching and proposing suggestions for the company's long-term development strategy, major investment decisions, and significant operational projects [3]. - The committee is accountable to the board of directors, and any proposals not fully adopted by the board must be documented along with reasons for non-adoption [3][4]. Meeting Procedures - The committee can hold meetings as needed, with any member able to propose a temporary meeting [4]. - Meetings require the presence of at least two-thirds of the members to be valid, and decisions must be approved by a majority [4][5]. - Voting can be conducted through various means, including electronic methods, ensuring all members can express their opinions [5]. Confidentiality and Record Keeping - Members are obligated to maintain confidentiality regarding meeting discussions and must adhere to the company's information management policies [5]. - Meeting records must be kept for at least ten years, and all attendees must sign the records [5]. Implementation and Amendments - The working rules take effect upon approval by the board and are subject to relevant national laws and regulations [5]. - The board holds the authority to interpret these rules [5].

Core Viewpoint - The document outlines the rules and regulations governing the board of directors of Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd, emphasizing the importance of clear governance structures, responsibilities, and the qualifications required for directors to ensure effective decision-making and compliance with legal standards [1]. Chapter Summaries Chapter 1: General Principles - The rules are established to clarify the powers of the board, standardize internal operations, and enhance decision-making efficiency [1]. Chapter 2: Directors - Directors must be natural persons and are not required to hold shares in the company [2]. - Certain disqualifications for directors include lack of civil capacity, criminal convictions related to financial misconduct, and being a debtor listed as untrustworthy [2][3]. - Directors are elected for a term of three years, with the possibility of re-election [3][4]. - Directors must sign an employment contract detailing their rights and obligations [4][5]. - Directors have specific rights, including attending meetings and voting [5]. - Directors must adhere to fiduciary duties, including not misappropriating company assets or engaging in conflicts of interest [5][6]. Chapter 3: Independent Directors - Independent directors must not hold other positions within the company and should not have conflicts of interest with major shareholders [12]. - The number of independent directors must constitute at least one-third of the board [12]. - Independent directors are responsible for protecting the interests of minority shareholders and must provide independent opinions on significant transactions [12][15]. Chapter 4: Board Composition and Responsibilities - The board consists of ten non-employee directors and one employee director, including four independent directors [22]. - The board is responsible for convening shareholder meetings, executing resolutions, and making key operational decisions [22][23]. - The board has the authority to approve significant financial transactions and investments, subject to certain thresholds [24][25]. Chapter 5: Chairman and Vice Chairman - The chairman and vice chairman are elected by the board and serve a term of three years [50]. - The election process requires a majority vote from the board members [51].

广州白云山医药集团股份有限公司 股东会议事规则 （经本公司 2025 年 8 月 15 日召开的第九届董事会第二十八次会议 审议通过） 第一章 总则 第一条 为提高股东会议事效率，保证股东会会议程序及决议 的合法性，充分维护全体股东的合法权益，根据《中华人民共和国 公司法》（以下简称"《公司法》"）、《中华人民共和国证券法》 （以下简称"《证券法》"）、《上市公司股东会规则》《上市公 司治理准则》《广州白云山医药集团股份有限公司章程》（以下简 称"《公司章程》"）及境内外其他有关法律、行政法规、上市所 在地证券监督管理机构或者证券交易所相关规定，制定本议事规则。 第二条 广州白云山医药集团股份有限公司（以下简称"本公 司"或"公司"）股东会的召集、提案、通知、召开等事项适用本 议事规则。 第三条 本公司应当严格按照法律、行政法规、上市所在地证 券监督管理机构或者证券交易所相关规定、《公司章程》及本议事 规则的相关规定召开股东会，保证股东能够依法行使权利。股东会 应当在《公司法》和《公司章程》规定的范围内行使职权。 本公司董事会应当切实履行职责，认真、按时组织股东会。本 公司全体董事应当勤勉尽责，确保股东会正常 ...

Core Points - The document outlines the rules for the board of directors of Guangzhou Weili Medical Equipment Co., Ltd, aiming to standardize the decision-making process and enhance the board's operational efficiency [1][2][3] Group 1: Meeting Types and Procedures - The board meetings are categorized into regular and temporary meetings, with at least one regular meeting required in each half of the year [2] - The chairman must consult with the general manager and other senior management before proposing agenda items for regular meetings [2][3] - Temporary meetings can be called under specific circumstances, such as requests from shareholders or the chairman [2][3] Group 2: Meeting Notifications and Attendance - Notifications for regular meetings must be sent ten days in advance, while temporary meetings require five days' notice [3][4] - The meeting notice must include essential details such as time, location, and agenda items [4][5] - Directors are expected to attend meetings in person, but can delegate their attendance under certain conditions [5][6] Group 3: Voting and Decision-Making - Decisions require a majority vote from the attending directors, with specific rules for abstentions and conflicts of interest [8][10] - Proposals not passed cannot be reconsidered within a month unless significant changes occur [11] - The board must ensure that decisions are made within the authority granted by the shareholders and the company's articles of association [10][12] Group 4: Documentation and Record-Keeping - Meeting records must be accurate and include details such as attendance, proposals discussed, and voting results [12][14] - The board secretary is responsible for maintaining all meeting documentation for a minimum of ten years [14] - Any dissenting opinions must be documented, and confidentiality regarding the decisions is mandatory until official announcements are made [13][14]